Cargando…

Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive neoplasm characterized by a marked fibro-inflammatory microenvironment(1), the presence of which can promote both cancer induction and growth(2–4). Therefore, selective manipulation of local cytokines is an attractive if unrealized thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alam, Muhammad S., Gaida, Matthias M., Bergmann, Frank, Lasitschka, Felix, Giese, Thomas, Giese, Nathalia A., Hackert, Thilo, Hinz, Ulf, Hussain, S. Perwez, Kozlov, Serguei V., Ashwell, Jonathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636461/ https://www.ncbi.nlm.nih.gov/pubmed/26479921 http://dx.doi.org/10.1038/nm.3957

Ejemplares similares

Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10
por: Stern, Louisa, et al.
Publicado: (2018)

Counter-regulation of T cell effector function by differentially activated p38
por: Alam, Muhammad S., et al.
Publicado: (2014)

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2021)

Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
por: Dovzhanskiy, Dmitriy I, et al.
Publicado: (2012)

Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma
por: Heger, Ulrike, et al.
Publicado: (2022)

Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer
por: Throm, Verena M., et al.
Publicado: (2018)

Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma
por: Welsch, Thilo, et al.
Publicado: (2011)

Epithelial-to-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma and Pancreatic Tumor Cell Lines: The Role of Neutrophils and Neutrophil-Derived Elastase
por: Große-Steffen, Thomas, et al.
Publicado: (2012)

Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer
por: Linnebacher, Alica, et al.
Publicado: (2019)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma
por: Ghassem-Zadeh, Sahar, et al.
Publicado: (2017)

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients
por: Ahmed, Azaz, et al.
Publicado: (2023)

HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study
por: Schott, Sarah, et al.
Publicado: (2017)

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
por: Zhang, Yiyao, et al.
Publicado: (2015)

Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

The emerging field of pancreatic tissue engineering: A systematic review and evidence map of scaffold materials and scaffolding techniques for insulin-secreting cells
por: Salg, Gabriel Alexander, et al.
Publicado: (2019)

Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
por: Keleg, Shereen, et al.
Publicado: (2014)

Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer
por: Roth, Susanne, et al.
Publicado: (2020)

Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
por: Zhang, Chaoyang, et al.
Publicado: (2023)

Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer
por: Wu, Yenan, et al.
Publicado: (2021)

SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis
por: Manoochehri, Mehdi, et al.
Publicado: (2020)

Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis
por: Michalski, Christoph W, et al.
Publicado: (2007)

Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation
por: Alam, Muhammad S., et al.
Publicado: (2018)

Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
por: Michalski, Christoph W., et al.
Publicado: (2008)

Autoimmune Pancreatocholangitis, Non-Autoimmune Pancreatitis and Primary Sclerosing Cholangitis: A Comparative Morphological and Immunological Analysis
por: Esposito, Irene, et al.
Publicado: (2008)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer
por: Hank, Thomas, et al.
Publicado: (2023)

Objective parameters aid the prediction of fistulas in pancreatic surgery
por: FELIX, KLAUS, et al.
Publicado: (2014)

Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial
por: Lozanovski, Vladimir J, et al.
Publicado: (2014)

The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype
por: Mayer, Philipp, et al.
Publicado: (2020)

The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
por: D’Haese, Jan G, et al.
Publicado: (2013)

Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasms
por: Xu, Xiaojun, et al.
Publicado: (2020)

Tasting Pseudomonas aeruginosa Biofilms: Human Neutrophils Express the Bitter Receptor T2R38 as Sensor for the Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine Lactone
por: Maurer, Susanne, et al.
Publicado: (2015)

Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
por: Xie, Li, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition in Pancreatic Cancer is associated with Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging
por: Mayer, Philipp, et al.
Publicado: (2021)

Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin
por: Stern, Louisa, et al.
Publicado: (2022)

Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma
por: Mustafa, Shakhawan, et al.
Publicado: (2017)

On the inflammatory response in metal-on-metal implants
por: Dapunt, Ulrike, et al.
Publicado: (2014)

Toward 3D-bioprinting of an endocrine pancreas: A building-block concept for bioartificial insulin-secreting tissue
por: Salg, Gabriel A, et al.
Publicado: (2022)

Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitis
por: Zahn, Alexandra, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dd1rrscajnpdlnrir6s1shamtd